Information Request Form

Please enter your message in the form below. Your message will be emailed directly to the contact associated with the press release upon the submission of the form.

Press Release:
The Lancet Publishes Clinical Trial Data That Demonstrate Statistically Significant and Dose-Dependent Expression of Dystrophin in Duchenne Muscular Dystrophy Patients Treated With AVI BioPharma's Eteplirsen
Press Release Date:
07/25/2011 07:00 AM Eastern Time
Your Email Address: (Required)
Subject Line: (Required)
Your Name:
Your Title:
Your Company/Publication Name:
Your Message: (Required)

Information entered into this form will be relayed, solely to the Marketwire client contact that is associated with this release. Your privacy is important to us, and we make sure it is properly protected. Please see our privacy policy for more details.